Vaccine Research At Bavarian Nordic A/S Pharmaceuticals

An employee places samples inside a temperature controlled cabinet in laboratory at the Bavarian Nordic A/S biotechnology company, where the research into infectious diseases, including the ebola vaccine, takes place in Kvistgaard, Denmark, on Friday, Oct. 31, 2014. The ebola vaccine combines a shot from Johnson & Johnson's Janssen unit in the Netherlands with one developed by Bavarian Nordic, the U.S.-based company said. Photographer: Freya Ingrid Morales/Bloomberg via Getty Images
An employee places samples inside a temperature controlled cabinet in laboratory at the Bavarian Nordic A/S biotechnology company, where the research into infectious diseases, including the ebola vaccine, takes place in Kvistgaard, Denmark, on Friday, Oct. 31, 2014. The ebola vaccine combines a shot from Johnson & Johnson's Janssen unit in the Netherlands with one developed by Bavarian Nordic, the U.S.-based company said. Photographer: Freya Ingrid Morales/Bloomberg via Getty Images
Vaccine Research At Bavarian Nordic A/S Pharmaceuticals
PURCHASE A LICENCE
How can I use this image?
₹23,000.00
INR

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
458177780
Collection:
Bloomberg
Date created:
31 October, 2014
Upload date:
Licence type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
DENMARK PHARMA
Max file size:
2667 x 4000 px (22.58 x 33.87 cm) - 300 dpi - 2 MB